Comments
Loading...

Cara Therapeutics

CARANASDAQ
Logo brought to you by Benzinga Data
$0.4226
0.013.35%
At close: -
$0.4089
-0.01-3.24%
After Hours: Dec 20, 7:59 PM EDT
Tvardi Therapeutics, Inc announced it will be merged with Cara Therapeutics (CARA) on Wednesday, December 18, 2024

Cara Therapeutics (NASDAQ:CARA) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Cara Therapeutics (CARA)?

A

There have been no specific sales or earnings guidance reported for Cara Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch